Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists

被引:10
|
作者
Sun, Wenjing [1 ]
Yang, Fan [1 ]
Zhang, Huanhuan [1 ]
Yuan, Qingning [2 ]
Ling, Shenglong [1 ]
Wang, Yuanxia [1 ]
Lv, Pei [1 ]
Li, Zelin [1 ]
Luo, Yifan [1 ]
Liu, Dongsheng [3 ]
Yin, Wanchao [2 ,4 ,5 ]
Shi, Pan [1 ]
Xu, H. Eric [2 ,5 ,6 ]
Tian, Changlin [1 ,2 ,7 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Endocrinol, Inst Endocrine & Metab Dis,Sch Life Sci,Div Life S, Hefei, Anhui, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
[3] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China
[4] Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan, Guangdong, Peoples R China
[5] Univ Chinese Acad Sci, Beijing, Peoples R China
[6] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
[7] Chinese Acad Sci, Anhui Prov Key Lab High Magnet Resonance Image, High Magnet Field Lab, Hefei, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
TACHYKININ RECEPTORS; ARCUATE NUCLEUS; KISSPEPTIN NEURONS; NEUROMEDIN-K; DYNORPHIN-A; RAT; NK3; EXPRESSION; SYSTEM; LOCALIZATION;
D O I
10.1038/s41421-023-00564-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neurokinin 3 receptor (NK3R) is a tachykinin receptor essential for the hypothalamic-pituitary-gonadal axis. The endogenous peptide agonist neurokinin B (NKB) preferentially activates NK3R, while substance P (SP) binds preferentially to NK1R. In addition, the SP analogue senktide more potently activates NK3R than NKB and SP. However, the mechanisms of preferential binding of peptide and NK3R activation remain elusive. Herein, we determined the cryogenic electron microscopy (cryo-EM) structures of the NK3R-G(q) complex bound to NKB, SP and senktide. The three NK3R-G(q)/peptide complexes utilize a class of noncanonical receptor activation mechanisms. Combining the structural analysis and functional assay illustrated that the consensus C-termini of the three peptide agonists share a conserved binding mode to NK3R, while the divergent N-termini of the peptides confer the preferential binding of the agonist to NK3R. In addition, the specific interactions between the N-terminus of senktide and the N-terminus and extracellular loops (ECL2 and ECL3) of NK3R lead to the improved activation displayed by senktide compared to SP and NKB. These findings pave the way to understand tachykinin receptor subtype selectivity and provide ideas to rationally develop drugs targeting NK3R.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Author Correction: Structural insights into μ-opioid receptor activation
    Weijiao Huang
    Aashish Manglik
    A. J. Venkatakrishnan
    Toon Laeremans
    Evan N. Feinberg
    Adrian L. Sanborn
    Hideaki E. Kato
    Kathryn E. Livingston
    Thor S. Thorsen
    Ralf C. Kling
    Sébastien Granier
    Peter Gmeiner
    Stephen M. Husbands
    John R. Traynor
    William I. Weis
    Jan Steyaert
    Ron O. Dror
    Brian K. Kobilka
    Nature, 2020, 584 : E16 - E16
  • [32] Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists
    Li, Jingru
    You, Chongzhao
    Li, Yang
    Li, Changyao
    Fan, Wenjia
    Chen, Zecai
    Hu, Wen
    Wu, Kai
    Xu, H. Eric
    Zhao, Li-Hua
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (26)
  • [33] Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
    Gavryushov, Sergei
    Bashilov, Anton
    Cherashev-Tumanov, Konstantin V.
    Kuzmich, Nikolay N.
    Burykina, Tatyana I.
    Izotov, Boris N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [34] Structural insights into ligand recognition, selectivity, and activation of bombesin receptor subtype-3
    Li, Changyao
    Xu, Youwei
    Su, Wenxin
    He, Xinheng
    Li, Jingru
    Li, Xinzhu
    Xu, H. Eric
    Yin, Wanchao
    CELL REPORTS, 2024, 43 (08):
  • [35] Structural insights into the agonists binding and receptor selectivity of human histamine H4 receptor
    Dohyun Im
    Jun-ichi Kishikawa
    Yuki Shiimura
    Hiromi Hisano
    Akane Ito
    Yoko Fujita-Fujiharu
    Yukihiko Sugita
    Takeshi Noda
    Takayuki Kato
    Hidetsugu Asada
    So Iwata
    Nature Communications, 14
  • [36] Structural insights into the agonists binding and receptor selectivity of human histamine H4 receptor
    Im, Dohyun
    Kishikawa, Jun-ichi
    Shiimura, Yuki
    Hisano, Hiromi
    Ito, Akane
    Fujita-Fujiharu, Yoko
    Sugita, Yukihiko
    Noda, Takeshi
    Kato, Takayuki
    Asada, Hidetsugu
    Iwata, So
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [37] Discovery and structural development of novel natriuretic peptide receptor A (NPR-A) agonists
    Iwaki, Takehiko
    Oyama, Yoshiaki
    Tomoo, Toshiyuki
    Tanaka, Taisaku
    Sugiyama, Masako
    Yamaki, Akira
    Furuya, Mayumi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [38] Cellular metabolism of substance P produces neurokinin-1 receptor peptide agonists with diminished cyclic AMP signaling
    Kriska, Tamas
    Natarajan, Jayashree
    Herrnreiter, Anja
    Park, Sang-Kyu
    Pfister, Sandra L.
    Thomas, Michael J.
    Widiapradja, Alexander
    Levick, Scott P.
    Campbell, William B.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2024, 327 (01): : C151 - C167
  • [39] Synthesis and evaluation of peptide-fentanyl analogue conjugates as dual μ/δ-opioid receptor agonists for the treatment of pain
    Li, Jing
    Zhang, Tao
    Sun, Jialin
    Ren, Fengxia
    Jia, Hongxin
    Yu, Zixing
    Cheng, Jingchao
    Shi, Weiguo
    CHINESE CHEMICAL LETTERS, 2022, 33 (08) : 4107 - 4110
  • [40] Development of Novel Neurokinin 3 Receptor (NK3R) Selective Agonists with Resistance to Proteolytic Degradation
    Misu, Ryosuke
    Oishi, Shinya
    Yamada, Ai
    Yamamura, Takashi
    Matsuda, Fuko
    Yamamoto, Koki
    Noguchi, Taro
    Ohno, Hiroaki
    Okamura, Hiroaki
    Ohkura, Satoshi
    Fujii, Nobutaka
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (20) : 8646 - 8651